| Name | zinc finger protein 66 |
| Description | Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in membrane and nucleus. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nGPR55 is an atypical cannabinoid‐sensing G protein–coupled receptor widely expressed throughout the central nervous system that modulates neuronal excitability, synaptic plasticity, and neuroimmune signaling. Experimental models have revealed that activation or deletion of GPR55 affects nociceptive thresholds, alters inflammatory mediator release by microglia, and even influences hippocampal long‐term potentiation—findings that collectively point to its importance in pain processing, stress responses, and higher order behaviors. In rodent studies, genetic deletion or pharmacological blockade of GPR55 attenuated inflammatory and neuropathic hyperalgesia and modified neurotransmitter release in brain areas such as the hippocampus and periaqueductal gray, while changes in receptor expression were linked to aberrant anxiety‐ and depression‐like states and deficits in adult neurogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its central actions, GPR55 plays a pivotal role in the regulation of peripheral metabolic and endocrine functions. It is highly expressed in pancreatic islets and has been implicated in stimulus–secretion coupling and calcium signaling that enhance insulin secretion; indeed, both genetic ablation of GPR55 and pharmacological modulation alter glucose tolerance and insulin sensitivity in rodent models of diabetes. Furthermore, in tissues such as skeletal muscle, adipose tissue, and liver, activation of GPR55 promotes insulin signaling and regulates energy homeostasis, and recent evidence also indicates a role in lipid metabolism and diabetic nephropathy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of oncogenesis, GPR55 functions as a pro‐tumorigenic modulator in several cancer models. Studies have demonstrated that GPR55 enhances cell proliferation, anchorage–independent growth, and invasiveness in cancers such as squamous cell carcinoma and pancreatic ductal adenocarcinoma. Tumors with elevated GPR55 expression typically display increased aggressiveness, suggesting that the receptor not only drives malignant transformation but may also serve as a potential biomarker and therapeutic target in oncology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in the central nervous system, metabolic regulation, and cancer, GPR55 contributes to diverse peripheral physiological processes. In bone biology, for instance, GPR55 modulates osteoclast differentiation and resorptive activity, thereby influencing bone remodeling and homeostasis. Similarly, in the gastrointestinal tract, GPR55 regulates motility and local inflammatory responses, while in the cardiovascular system it partakes in the regulation of vascular tone and myocardial remodeling. Recent investigations have also identified a role for GPR55 in exocrine processes, where its activation enhances salivary gland function and glycoprotein secretion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Penny C Staton, Jon P Hatcher, Deborah J Walker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pain (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.pain.2008.04.006"}], "href": "https://doi.org/10.1016/j.pain.2008.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18502582"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18502582"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Maciej Pietr, Ewa Kozela, Rivka Levy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential changes in GPR55 during microglial cell activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2009.05.028"}], "href": "https://doi.org/10.1016/j.febslet.2009.05.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19464294"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19464294"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sergiy Sylantyev, Thomas P Jensen, Ruth A Ross, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1211204110"}], "href": "https://doi.org/10.1073/pnas.1211204110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23472002"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23472002"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Elena Deliu, Margaret Sperow, Linda Console-Bram, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.115.099333"}], "href": "https://doi.org/10.1124/mol.115.099333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25972448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25972448"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mikael Bjursell, Erik Ryberg, Tingting Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0167965"}], "href": "https://doi.org/10.1371/journal.pone.0167965"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27941994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27941994"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lawrence M Carey, Tannia Gutierrez, Liting Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-01062-2"}], "href": "https://doi.org/10.1038/s41598-017-01062-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28428628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28428628"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jeremy D Hill, Viviana Zuluaga-Ramirez, Sachin Gajghate, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bph.14387"}], "href": "https://doi.org/10.1111/bph.14387"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29888782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29888782"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jeremy D Hill, Viviana Zuluaga-Ramirez, Sachin Gajghate, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Behav Immun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbi.2018.11.017"}], "href": "https://doi.org/10.1016/j.bbi.2018.11.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30465881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30465881"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "E R Hawken, C P Normandeau, J Gardner Gregory, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41386-018-0309-0"}], "href": "https://doi.org/10.1038/s41386-018-0309-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30647449"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30647449"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Maria Giovanna Mosca, Maria Mangini, Stefania Cioffi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Commun Signal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12964-021-00727-w"}], "href": "https://doi.org/10.1186/s12964-021-00727-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33902596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33902596"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Qingqing Liu, Jiaoyan Yu, Xi Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Psychopharmacology (Berl) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00213-021-05949-x"}], "href": "https://doi.org/10.1007/s00213-021-05949-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34648060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34648060"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shi-Yu Shen, Rui Yu, Wei Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The neuroprotective effects of GPR55 against hippocampal neuroinflammation and impaired adult neurogenesis in CSDS mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2022.105743"}], "href": "https://doi.org/10.1016/j.nbd.2022.105743"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35490927"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35490927"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Teruaki Ono, Tomohiro Yamashita, Ryota Kano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 contributes to neutrophil recruitment and mechanical pain induction after spinal cord compression in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Behav Immun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbi.2023.03.008"}], "href": "https://doi.org/10.1016/j.bbi.2023.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36898418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36898418"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Yi He, Hui Shen, Guo-Hua Bi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41398-024-02820-3"}], "href": "https://doi.org/10.1038/s41398-024-02820-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38374108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38374108"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Silvana Y Romero-Zerbo, Alex Rafacho, Adenis Díaz-Arteaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Endocrinol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/JOE-11-0166"}], "href": "https://doi.org/10.1530/JOE-11-0166"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21885477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21885477"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "A M McKillop, B M Moran, Y H A Abdel-Wahab, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bph.12356"}], "href": "https://doi.org/10.1111/bph.12356"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23992544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23992544"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Kayte A Jenkin, Andrew J McAinch, Yuan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Pharmacol Physiol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1440-1681.12355"}], "href": "https://doi.org/10.1111/1440-1681.12355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25545857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25545857"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Bo Liu, Shuang Song, Inmaculada Ruz-Maldonado, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Obes Metab (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/dom.12780"}], "href": "https://doi.org/10.1111/dom.12780"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27561953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27561953"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Marcos F Fondevila, Uxia Fernandez, Maria J Gonzalez-Rellan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.31290"}], "href": "https://doi.org/10.1002/hep.31290"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32329085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32329085"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Andrew G McCloskey, Michael G Miskelly, Ryan A Lafferty, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2022.115398"}], "href": "https://doi.org/10.1016/j.bcp.2022.115398"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36581052"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36581052"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Lyndsey L Anderson, Dilara A Bahceci, Nicole A Hawkins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0280842"}], "href": "https://doi.org/10.1371/journal.pone.0280842"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36701411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36701411"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Bo Liu, Inmaculada Ruz-Maldonado, Shanta J Persaud "}, {"type": "b", "children": [{"type": "t", "text": "Global deletion of G protein-coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β-cell turnover."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Obes Metab (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/dom.15816"}], "href": "https://doi.org/10.1111/dom.15816"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39113250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39113250"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "E Pérez-Gómez, C Andradas, J M Flores, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.278"}], "href": "https://doi.org/10.1038/onc.2012.278"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22751111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22751111"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "R Ferro, A Adamska, R Lattanzio, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0390-1"}], "href": "https://doi.org/10.1038/s41388-018-0390-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30061636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30061636"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Christopher Lipina, Sarah K Walsh, Sharon E Mitchell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201800171R"}], "href": "https://doi.org/10.1096/fj.201800171R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30148676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30148676"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Kan Zhai, Xin-Yu Shi, Feng-Shuang Yi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL-10 promotes malignant pleural effusion by regulating T"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "H"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " 1 response via an miR-7116-5p/GPR55/ERK pathway in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.202048574"}], "href": "https://doi.org/10.1002/eji.202048574"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32506440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32506440"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Lauren S Whyte, Erik Ryberg, Natalie A Sims, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0902743106"}], "href": "https://doi.org/10.1073/pnas.0902743106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19805329"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19805329"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "X-H Lin, B Yuece, Y-Y Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogastroenterol Motil (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2982.2011.01742.x"}], "href": "https://doi.org/10.1111/j.1365-2982.2011.01742.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21726355"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21726355"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Kun Li, Jakub Fichna, Rudolf Schicho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuropharm.2013.03.029"}], "href": "https://doi.org/10.1016/j.neuropharm.2013.03.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23603203"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23603203"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Thad Wilkins "}, {"type": "b", "children": [{"type": "t", "text": "A Family Physician Confronts Parkinson Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am Fam Physician (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26447438"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26447438"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Magdalena Grill, Carina Hasenoehrl, Melanie Kienzl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histochem Cell Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00418-018-1719-0"}], "href": "https://doi.org/10.1007/s00418-018-1719-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30196316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30196316"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Solomiia Korchynska, Mirjam I Lutz, Erzsébet Borók, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JCI Insight (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/jci.insight.122947"}], "href": "https://doi.org/10.1172/jci.insight.122947"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30830860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30830860"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Chi Teng Vong, Hisa Hui Ling Tseng, Yiu Wa Kwan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.12.126"}], "href": "https://doi.org/10.1016/j.biopha.2018.12.126"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30841431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30841431"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Olivia J Robertson-Gray, Sarah K Walsh, Erik Ryberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "l-α-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK-dependent pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res Perspect (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/prp2.487"}], "href": "https://doi.org/10.1002/prp2.487"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31149342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31149342"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sarah K Walsh, Christopher Lipina, Sheng Y Ang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GPR55 regulates the responsiveness to, but does not dimerise with, α"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "1A"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "-adrenoceptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2021.114560"}], "href": "https://doi.org/10.1016/j.bcp.2021.114560"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33844984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33844984"}]}]}]}
|
| Synonyms | ZNF66P |
| Proteins | ZNF66_HUMAN |
| NCBI Gene ID | 7617 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ZNF66 has 1,272 functional associations with biological entities spanning 6 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 36 datasets.
Click the + buttons to view associations for ZNF66 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZNF66 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF66 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of ZNF66 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ZNF66 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing ZNF66 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ZNF66 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZNF66 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with ZNF66 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with ZNF66 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GAD Gene-Disease Associations | diseases associated with ZNF66 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving ZNF66 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ZNF66 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by ZNF66 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ZNF66 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of ZNF66 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ZNF66 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ZNF66 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF66 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ZNF66 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF66 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of ZNF66 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of ZNF66 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZNF66 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with ZNF66 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ZNF66 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| NURSA Protein Complexes | protein complexs containing ZNF66 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZNF66 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of ZNF66 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ZNF66 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ZNF66 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ZNF66 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of ZNF66 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of ZNF66 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of ZNF66 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ZNF66 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ZNF66 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |